AssetMark Inc’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

AssetMark Inc’s Portfolio RARX Stock Details RARX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-25	Closed	-$1K	–	1509
2020 Q1	$1K	Buy	+25	New	+$1.16K	﹤0.01%	1337

Other funds holding RARX

Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

AssetMark Inc's RARX Position: Q2 2020 in Review

AssetMark Inc sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q2 2020, closing a stake of 25 shares — an estimated $1K sold.

AssetMark Inc first reported a position in RARX in Q1 2020 and held it in 1 quarter. The position peaked at $1K in Q1 2020. 1 fund tracked by Wall St. Rank holds RARX as of Q2 2020.

AssetMark Inc reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
AssetMark Inc sold 25 Ra Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $1K.
AssetMark Inc first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q1 2020 and held it in 1 quarter.
AssetMark Inc's Ra Pharmaceuticals, Inc. Common Stock position peaked at $1K in Q1 2020.
1 fund tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on AssetMark Inc's 13F filing for Q2 2020, filed 11 Aug 2020.